Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Most protocols allow one injection per week, with flexibility of 2 days from your scheduled day without medical oversightthough your provider should approve any intentional schedule change
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management
2003 Oct;66(8):14991503.
Risk factors and considerations Because semaglutide may increase resting heart rate, it may be an unsafe drug for some individuals
US$ 25.77
US$ 25.80
US$ 29.69
US$ 26.68
US$ 22.05
US$ 26.52
